https://www.sciencedaily.com/releases/2014/03/140320121912.htm
Inhibition of CDK4 might promote lymphoma development, progression | ScienceDaily
Anticancer agents that inhibit tumor growth by targeting a cell-cycle regulatory protein called CDK4 might actually promote the development and progression of...
development progressioninhibitioncdk4mightpromote